Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate
DoD funding aims to advance F. tularensis biodefense vaccine candidate to IND submission Appili Therapeutics Inc. announced this week that ...
DoD funding aims to advance F. tularensis biodefense vaccine candidate to IND submission Appili Therapeutics Inc. announced this week that ...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is soliciting research ...
The Federal Select Agent Program dictates that all research entities in the United States must rigorously assess laboratory protocols to ...
Francisella tularensis, also called rabbit fever, is an equal opportunity pathogen: it causes the disease tularemia in humans, rabbits and ...
Renowned microbiologist Henry “Hank” Eigelsbach died of natural causes on December 6, 2019 at the age of 100. The former ...
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable ...
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...
The U.S. federal government is backing an antibiotic that not only holds potential as a treatment for infections from certain ...
At left, principal investigator Jean Challacombe, assisted by Cheryl Gleasner, work on sequencing the Francisella genomes at Los Alamos. The ...
A negative stain electron micrograph of a dense culture of Francisella bacteria.Credit: Alexandra Walls and Aria Eshraghi Scientists are gaining ...
LLNL biologist Crystal Jaing with the structural model of topoisomerase enzyme FTL_1547. A mutation position is colored in red. Photo by ...
The U.K. Defence Science and Technology Laboratory (Dstl) has received funding of up to $6.9 million from the U.S. Defense ...
The total number of incidents involving incomplete inactivation—a process to destroy the hazardous effects of pathogens while retaining characteristics for ...
Military program managers briefed biopharmaceutical industry and research organization representatives during a Nov. 2 Industry Day, part of an initiative ...
Biopharmaceutical company Arno Therapeutics, Inc. has announced promising data demonstrating novel activity of AR-12 as a broad-spectrum, anti-microbial drug. Results ...
The National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) to support development ...
Research led by scientists at St. Jude Children's Research Hospital has identified key molecules that trigger the immune system to ...
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information regarding efforts to develop therapeutic products that demonstrate activity ...
DIATHERIX Laboratories, Inc., has been awarded a second federal contract to continue its work in the development of methodologies for ...
Emergent BioSolutions today announced that it has acquired the lead broad-spectrum antibiotic candidate, currently receiving Defense Threat Reduction Agency (DTRA) development ...